Peringkat dalam Saham
#33455
Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing... Anew Medical, Inc. is a biopharmaceutical firm dedicated to developing innovative treatments for conditions affecting the brain and nervous system, age-related illnesses, and specialized diagnostic tools. Their pipeline includes advanced cell and gene therapies specifically designed to alleviate symptoms of aging-related conditions, such as dementia, Alzheimer's disease, and various neuromuscular disorders. Additionally, Anew Medical is engaged in developing biologics and biosimilars for cancer treatment, alongside research into therapies targeting melanocortin receptors. A key strategic alliance exists with Japan's Okinawa Research Center, focusing on the collaborative research and development of Klotho gene therapy. This initiative aims to extend human longevity and diminish the impact of age-related diseases. The company maintains its headquarters in Omaha, Nebraska.
Harga Saham
$0.5099
Terakhir disinkronkan: 2024-10-15
Kapitalisasi Pasar
$7.60M
Perubahan (1 tahun)
0.00%
Perdagangan Anew Medical, Inc. (WENA)
Harga WENA dengan kapitalisasi pasar B
Kapitalisasi pasar dari Anew Medical, Inc.(WENA)
Kapitalisasi Pasar: $7.60M
Per August 2026, Anew Medical, Inc. memiliki kapitalisasi pasar sebesar $7.60M. Ini menjadikan Anew Medical, Inc. sebagai perusahaan 33455th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Anew Medical, Inc. dari 2024 hingga 2026
WENA dibandingkan dengan 5 teratas stocks paling populer
| Harga WENA |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.452T
|
+71,731,742.10%
|
|
|
|
|
$4.490T
|
+59,076,428.18%
|
|
|
|
|
$4.162T
|
+54,765,924.71%
|
|
|
|
|
$3.676T
|
+48,370,628.76%
|
|
|
|
|
$2.833T
|
+37,275,082.79%
|
